ARTICLE DATE: May 13, 2013
The Efficacy and Mechanism Evaluation Programme (EME Programme) aims to support excellent clinical science with an ultimate view to improving health or patient care.
Broadly, while the Experimental Medicine schemes address the proof of concept and “can it work?” questions, the EME Programme examines the efficacy of the intervention (“does it work?”) to the point where, in the example of a drug, a marketing authorisation could be sought or widespread use in healthcare supported. The safety of the intervention is also a subject for the EME Programme. The HTA Programme considers clinical and cost effectiveness ("is it worth it?").
Funding is now available for these projects and if you are interested please click on the following links:
Please note there are two deadlines that need to be met - 1 pm on 3 June 2013 and 1 pm on 1 October 2013. See the website for more information.
Best Practice London & Women’s Health Professional Care 2025 returns to Olympia London on 26-27 February 2025. This free-to-attend event brings together over 2,000 healthcare professionals working in general practice, primary care, and primary care-f...
Hair loss is a common presentation; it can affect anyone, at any age, and can occur anywhere on the body.
Intensive in-depth three month course to upskill primary care health care professionals in the assessment and management of people with skin conditions.
The October PCDS Skin Club will focus on members who work as Primary Care Professionals (PCPs), our range of members include podiatrists, nurses, ACPs, physician’s associates, pharmacists paramedics and others.
The following pharmaceutical companies have had no involvement in the content of this website or in our conference programmes
